Latest Insider Transactions at 1 Life Healthcare Inc (ONEM)
This section provides a real-time view of insider transactions for 1 Life Healthcare Inc (ONEM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 1Life Healthcare Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 1Life Healthcare Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2022
|
Mary Ann Tocio |
BUY
Grant, award, or other acquisition
|
Direct |
730
+1.54%
|
-
|
|
Oct 15
2022
|
Scott C Taylor |
BUY
Grant, award, or other acquisition
|
Direct |
730
+9.44%
|
-
|
|
Oct 15
2022
|
David P Kennedy |
BUY
Grant, award, or other acquisition
|
Direct |
730
+7.11%
|
-
|
|
Oct 15
2022
|
Bruce Dunlevie |
BUY
Grant, award, or other acquisition
|
Direct |
1,023
+8.15%
|
-
|
|
Oct 15
2022
|
Paul R. Auvil Iii |
BUY
Grant, award, or other acquisition
|
Direct |
1,023
+8.15%
|
-
|
|
Oct 12
2022
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,610
+46.55%
|
$88,270
$7.93 P/Share
|
|
Oct 07
2022
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
1,371,117
-93.22%
|
$23,308,989
$17.03 P/Share
|
|
Oct 07
2022
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,371,117
+31.01%
|
$9,597,819
$7.79 P/Share
|
|
Oct 06
2022
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
1,825,289
-94.82%
|
$31,029,913
$17.08 P/Share
|
|
Oct 06
2022
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,825,289
+48.67%
|
$7,301,156
$4.01 P/Share
|
|
Oct 05
2022
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
2,123,402
-95.51%
|
$36,097,834
$17.09 P/Share
|
|
Oct 05
2022
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,123,402
+48.85%
|
$8,493,608
$4.01 P/Share
|
|
Oct 04
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
133,838
-60.23%
|
$2,275,246
$17.18 P/Share
|
|
Oct 04
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
133,838
+17.03%
|
$1,338,380
$10.74 P/Share
|
|
Oct 04
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
325,575
-99.43%
|
$5,534,775
$17.18 P/Share
|
|
Oct 04
2022
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
298,570
+47.69%
|
$2,089,990
$7.93 P/Share
|
|
Oct 04
2022
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Indirect |
249,377
-75.0%
|
$4,239,409
$17.18 P/Share
|
|
Oct 04
2022
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
1,613,937
-94.18%
|
$27,436,929
$17.17 P/Share
|
|
Oct 04
2022
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,613,937
+24.93%
|
$6,455,748
$4.01 P/Share
|
|
Sep 01
2022
|
Mary Ann Tocio |
BUY
Exercise of conversion of derivative security
|
Direct |
3,301
+6.72%
|
-
|
|
Aug 15
2022
|
Vikas Agarwal Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
394
-6.31%
|
$6,698
$17.14 P/Share
|
|
Aug 15
2022
|
Vikas Agarwal Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,080
+14.74%
|
-
|
|
Jul 15
2022
|
David P Kennedy |
BUY
Grant, award, or other acquisition
|
Direct |
1,369
+13.46%
|
-
|
|
Jul 15
2022
|
Mary Ann Tocio |
BUY
Grant, award, or other acquisition
|
Direct |
1,369
+3.13%
|
-
|
|
Jul 15
2022
|
Scott C Taylor |
BUY
Grant, award, or other acquisition
|
Direct |
1,369
+17.92%
|
-
|
|
Jul 15
2022
|
Bruce Dunlevie |
BUY
Grant, award, or other acquisition
|
Direct |
1,916
+15.42%
|
-
|
|
Jul 15
2022
|
Paul R. Auvil Iii |
BUY
Grant, award, or other acquisition
|
Direct |
1,916
+15.42%
|
-
|
|
Jun 02
2022
|
Paul R. Auvil Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
4,534
+34.53%
|
-
|
|
Jun 02
2022
|
Mark S. Blumenkranz |
BUY
Exercise of conversion of derivative security
|
Direct |
4,534
+50.0%
|
-
|
|
Jun 02
2022
|
Bruce Dunlevie |
BUY
Exercise of conversion of derivative security
|
Direct |
4,534
+34.53%
|
-
|
|
Jun 02
2022
|
Holmes Kalen |
BUY
Exercise of conversion of derivative security
|
Direct |
4,534
+50.0%
|
-
|
|
Jun 02
2022
|
David P Kennedy |
BUY
Exercise of conversion of derivative security
|
Direct |
4,534
+37.88%
|
-
|
|
Jun 02
2022
|
Freda C Lewis Hall |
BUY
Exercise of conversion of derivative security
|
Direct |
4,534
+50.0%
|
-
|
|
Jun 02
2022
|
Scott C Taylor |
BUY
Exercise of conversion of derivative security
|
Direct |
2,267
+31.62%
|
-
|
|
Apr 15
2022
|
Paul R. Auvil Iii |
BUY
Grant, award, or other acquisition
|
Direct |
1,643
+28.8%
|
-
|
|
Apr 15
2022
|
Bruce Dunlevie |
BUY
Grant, award, or other acquisition
|
Direct |
1,643
+28.8%
|
-
|
|
Apr 15
2022
|
Scott C Taylor |
BUY
Grant, award, or other acquisition
|
Direct |
1,173
+30.8%
|
-
|
|
Apr 15
2022
|
David P Kennedy |
BUY
Grant, award, or other acquisition
|
Direct |
1,173
+28.79%
|
-
|
|
Apr 15
2022
|
Mary Ann Tocio |
BUY
Grant, award, or other acquisition
|
Direct |
1,173
+2.78%
|
-
|
|
Feb 15
2022
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,777
+1.58%
|
-
|
|
Feb 15
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,422
-1.6%
|
$14,220
$10.26 P/Share
|
|
Feb 15
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,221
+2.44%
|
-
|
|
Jan 15
2022
|
Scott C Taylor |
BUY
Grant, award, or other acquisition
|
Direct |
768
+34.42%
|
-
|
|
Jan 15
2022
|
Paul R. Auvil Iii |
BUY
Grant, award, or other acquisition
|
Direct |
1,075
+30.77%
|
-
|
|
Jan 15
2022
|
Bruce Dunlevie |
BUY
Grant, award, or other acquisition
|
Direct |
1,075
+30.77%
|
-
|
|
Jan 15
2022
|
David P Kennedy |
BUY
Grant, award, or other acquisition
|
Direct |
768
+30.77%
|
-
|
|
Jan 15
2022
|
Mary Ann Tocio |
BUY
Grant, award, or other acquisition
|
Direct |
768
+1.89%
|
-
|
|
Dec 02
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
99,748
+22.22%
|
$398,992
$4.01 P/Share
|
|
Oct 15
2021
|
Paul R. Auvil Iii |
BUY
Grant, award, or other acquisition
|
Direct |
810
+37.6%
|
-
|
|
Oct 15
2021
|
David P Kennedy |
BUY
Grant, award, or other acquisition
|
Direct |
578
+37.58%
|
-
|